Posts page

Welcome to our new IAB members!

The ARC CPTT are delighted to welcome some new faces to our Industry Advisory Board (IAB). We are welcoming Andrew O’Brien from Clarivate Analytics and Bastian Stoehr from SMR! We were able to formally introduce them to the other members of our IAB at our most recent meeting.

Welcome Andrew and Bastian! We look forward to working with you both.

We would also like to thank outgoing members of the IAB, Gouri Betigeri (Clarivate Analytics) and Scott Edwards (SMR) for their contributions, and we wish them both well on their next endeavours.

PhD submissions – Congratulations Arianna & Helen!

The submission of a PhD thesis is an important milestone to celebrate. We are delighted to say that two of our Centre’s PhD students have just reached this stage of their candidature. Congratulations to Arianna Oddo and Qianyu (Helen) Chen! We invite you to learn a little more about them and their research below.

Arianna Oddo has undertaken her PhD at Monash University, under the supervision of Professor Nicolas Voelcker and Dr Tommy Tong. Her thesis title is “Microfluidic devices as novel in vitro platforms in the context of pre-clinical and toxicological studies”. Arianna has been active on Twitter during her PhD, demonstrating her skills in science communication. She has also been busy publishing her research in scientific journals, including Nanoscale Advances and Trends in Biotechnology. Click the links to read more!

Helen Chen undertook her PhD at The University of Melbourne, under the supervision of CPTT Director, Professor Alastair Stewart. Her thesis was titled “Organotypic airway epithelial cultures in modelling inflammation and infection”. Helen has also been an avid writer during her PhD, contributing to six publications so far (most recently in Biomicrofluidics), and another to be announced soon.

Congratulations again to Arianna and Helen on this milestone achievement in your academic careers!

R U OK? Day: Resources for 2021

Thursday September 9th is R U OK? Day. For many people this day acts as a prompt for us to ask friends, family and colleagues, “Are you OK?”.

The ARC CPTT is aware that not everyone will feel comfortable asking or indeed answering that question. We know that mental health is an ongoing discussion, beyond what a single day can encapsulate. The last two years have been extremely challenging for all of us, and so we are using this day as an opportunity to provide you with resources that will help you to ask and answer this question in the days, weeks and months ahead. Your conversation could save a life, and it is important to be equipped.

  • The first resource available is the R U OK? Day Workplace champions pack, which you can access here. Please take a moment to review the contents and consider saving a copy to your files.
  • The second resource is the R U OK? Day webinar, which will be run on R U OK? Day. Full details for the webinar are included below, and it is FREE to register.

Join the free R U OK? Day webinar 12.30pm Thurs 9 Sept (AEST)

Learn when and how to ask R U OK? so you can have a conversation that could change a life. Speakers include:

  • Sam Mac, weatherman Sunrise and R U OK? Ambassador
  • Katherine Newton, CEO R U OK?
  • Ann-Maree Fardell Hartley, psychologist and suicidoligist

Register here: https://www.eventbrite.com.au/e/2021-r-u-okday-webinar-tickets-166884491005

Read more about R U Ok? Day: https://www.ruok.org.au/join-r-u-ok-day

Watch the R U Ok? Day video: https://vimeo.com/574775905

We are a community, and we’re here to support you. Please reach out to us if you need support or assistance. 

Take care and stay safe. 

CPTT connection to mRNA vaccine manufacture

Photo credit: Monash University

Since global development of vaccines for COVID-19 became a reality, we in Australia have identified the critical value of producing vaccines onshore. That goal first became a reality with the AstraZeneca vaccine being produced in Melbourne by CSL. However, as we are now all aware, production of mRNA vaccines (Pfizer or Moderna) could not be achieved so easily.

Recently the Victorian Government provided Monash University with $5million to manufacture the first batch of a COVID-19 mRNA vaccine in Australia, to be used for clinical trials (utilising a vaccine candidate developed by researchers from the Monash Institute of Pharmaceutical Sciences). The team conducting this research is lead by CPTT chief investigator, Professor Colin Pouton.

Colin has been interviewed and quoted in many news articles and reports, especially in the last few months. However, we would like to draw your attention to a specific Opinion article Prof Pouton published in June in The Age newspaper titled ‘Australia set to join the mRNA vaccine revolution‘. Congratulations to Colin for bringing attention to the need for Australia to develop the manufacturing capabilities for production of medical and therapeutic technologies!

‘Materials, Mimics, & Microfluidics’ – CPTT conference success!

On July 21 – 23 our Centre participated in the ‘Materials, Mimics, & Microfluidics: Engineering Tools for Mechanobiology’ conference. In addition to members of our Centre being invited to present at the main meeting, we hosted two successful satellite meetings in Melbourne and Perth. The satellite events featured local researchers and the Melbourne event also included a PhD student ‘rapid fire’ session, sponsored by BOMP and MCN. Well done to Esther Lestrell and Tina Cheng who were the joint winners of the rapid fire session!

Congratulations to Dr Bryan Gao and Dr Roey Elnathan for their organisation of the Melbourne event, and to Dr Yu Suk Choi and Dr Brendan Kennedy for their organisation of the Perth event! All four were also invited speakers of the main conference and part of the meeting’s scientific committee. We thank them for their contributions to the conference and for their representation of ARC CPTT!

For those who were unable to attend and are interested to see more photos from the event, check out the hashtag #3M2021, which was used throughout the conference by participants from around the globe! Some of our own photos are included below.

2021 Organoids Are Us Symposium – Sponsored by ARC CPTT

The 2021 ‘Organoids Are Us’ symposium has been in planning for some time. Unfortunately the most recent lockdown in Melbourne has caused this event to go from in-person to virtual.

The ARC CPTT are delighted to be a Bronze Sponsor of the 2021 Organoids Are Us Symposium.

There is still time to register, and because the conference has gone virtual, registration is now FREE!

Click here to register, and view the flyer below to see details on the fantastic line up on national and international speakers! Congratulations to organisers, Professor Elizabeth Vincan and Dr Maree Faux.

2021 Women in Leadership Awards

In May the Royal Society of Victoria honored four exceptional leaders from the Biotech, Medtech and Pharmaceutical sectors of Victoria at the 2021 Women in Leadership Awards.

A heartfelt congratulations to all of the Awardees!

We are especially excited to congratulate Jennifer Herz, Managing Director of Biointelect and Partner Investigator in the CPTT. She was awarded the Inspiring Leadership Award for 2021! A fantastic honor that is well deserved. Congratulations Jenny!

Photo credit: BioMelbourne Network
From left: Dr Hannah Kirk (Emerging Leadership Awardee); Jennifer Herz (Inspiring Leadership Awardee); Dr Jenny Petering (Distinguished Leadership Awardee); A/Prof Margie Danchin (Board of Directors Awardee). Photo credit: BioMelbourne Network

International Women’s Day #IWD2021

Written by Centre Manager, Dr Susan Northfield

Today is International Women’s Day #IWD2021, and this year the theme is #ChooseToChallenge. “A challenged world is an alert world. Individually, we’re all responsible for our own thoughts and actions – all day, every day. We can all choose to challenge and call out gender bias and inequality. We can all choose to seek out and celebrate women’s achievements. Collectively, we can all help create an inclusive world.”

Our Centre has embraced the challenge to ensure diversity, gender equality and inclusion from day one; specifically identifying it as one of our key policies to make certain the Centre promotes a positive and fair workplace culture for all participants at all times. This policy guides our processes and decision-making as we develop opportunities for the students and ECRs in our care.

In the spirit of #ChooseToChallenge, we want to shine a light on what this approach looks like for us. For example, Centre participants are expected to:

  • Ensure invited speakers, panel compositions, other representatives required for Centre training and conferences etc., are of diverse backgrounds, including gender;
  • Ensure we advertise in such a way as to attract and subsequently enroll representative numbers of male/female students and postdoctoral researchers in the Centre;
  • Provide diversity in mentor-mentee pairs;
  • Provide key contacts at each University for anyone experiencing discrimination;
  • Adhere to the ten principles of the Athena SWAN Charter

Today we celebrate the women of our Centre – students, postdocs, chief investigators, executive members, and industry board members. The photo accompanying this post shows a handful of the women at our University of Melbourne #ARCCPTT node, from the Department of Biochemistry & Pharmacology. I want to thank them and all members of the Centre for contributing to providing a diverse, inclusive and supportive environment as we commit to #ChooseToChallenge and call out inequality. #IWD2021

Funding success for CPTT CI’s

The Centre congratulates two of our CI’s – Prof Spencer Williams & Prof Alastair Stewart – on their successful Accelerator Grant from Therapeutic Innovation Australia!

Their grant “Development of casein kinase 1 delta inhibitors for inflammation, fibrosis and fibrotic cancers” is in collaboration with Tianli Biotech Pty Ltd.

Outcomes for the recent round were announced at the end of February. For the full list of winners, visit the Therapeutic Innovation Australia website: https://www.therapeuticinnovation.com.au/p-accelerator2020-21-outcomes

New study: What makes you prone to tendon & ligament injuries?

Why are some people more prone to tendon and ligament injury than others?

We are delighted to promote a recent study by one of our CI’s, Prof Minghao Zheng, Director of the Centre for Translational Orthopaedic Research at The University of Western Australia and Chief Scientific Officer of our industry partner Orthocell.
This study has been published in top medical journal, Science Translational Medicine on February 25th. See a copy of the article here:  http://bit.ly/3suluH5

Prof. Zheng noted that the study offers new insights in the medical world by highlighting genetic factors responsible for sports injuries, including the commonly reported ACL rupture.

You can view the University of Western Australia’s press release, including a short video, via this link: https://www.uwa.edu.au/news/Article/2021/February/Some-more-prone-to-tendon-and-ligament-injuries